Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Ko

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Advances in Radiation Oncology|October 30, 2018
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionationEric C Ko, Kimberly Thomas Benjamin, Silvia C Formenti
JAMA Oncology|July 4, 2019
Analysis of Pathologic Complete Response 10 Weeks After Radiotherapy-A Radiobiological SinEric C Ko, Claire Vanpouille-Box, Silvia C Formenti
Current Opinion in Urology|August 9, 2017
Treatment strategies in low-volume metastatic castration-resistant prostate cancerXiao X Wei, Eric C Ko, Charles J Ryan
Cancer Research|August 3, 2005
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2Xinhui Wang, Eric C Ko, Liaomin Peng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2013
Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patientsEric C Ko, Jerry T Liu, Nelson N Stone, et al.
Critical Reviews in Oncology/Hematology|March 23, 2010
Targeting immune suppressing myeloid-derived suppressor cells in oncologyJohnny Kao, Eric C Ko, Samuel Eisenstein, et al.
Advances in Radiation Oncology|January 30, 2023
Definitive Radiation Therapy for Medically Inoperable Endometrial CarcinomaJames L Shen, Kevin W O'Connor, Janaki Moni, et al.
Oncology Reports|October 25, 2011
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiationEric C Ko, Eric M Genden, Krzysztof Misiukiewicz, et al.
Translational Lung Cancer Research|July 8, 2024
Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic <i>EGFR</i>-mutated non-small cell lung cancer: present and future developmentsXinchen Zhao, Shengwei Zhang, Xiaoyue Sun, et al.
Brachytherapy|February 16, 2010
Partial vs. whole breast irradiation in a community hospital: a retrospective cohort analysis of 200 patientsEric C Ko, Christopher D Koprowski, Diana Dickson-Witmer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Advances in Radiation Oncology|October 30, 2018
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionationEric C Ko, Kimberly Thomas Benjamin, Silvia C Formenti
JAMA Oncology|July 4, 2019
Analysis of Pathologic Complete Response 10 Weeks After Radiotherapy-A Radiobiological SinEric C Ko, Claire Vanpouille-Box, Silvia C Formenti
Current Opinion in Urology|August 9, 2017
Treatment strategies in low-volume metastatic castration-resistant prostate cancerXiao X Wei, Eric C Ko, Charles J Ryan
Cancer Research|August 3, 2005
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2Xinhui Wang, Eric C Ko, Liaomin Peng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 5, 2013
Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patientsEric C Ko, Jerry T Liu, Nelson N Stone, et al.
Critical Reviews in Oncology/Hematology|March 23, 2010
Targeting immune suppressing myeloid-derived suppressor cells in oncologyJohnny Kao, Eric C Ko, Samuel Eisenstein, et al.
Advances in Radiation Oncology|January 30, 2023
Definitive Radiation Therapy for Medically Inoperable Endometrial CarcinomaJames L Shen, Kevin W O'Connor, Janaki Moni, et al.
Oncology Reports|October 25, 2011
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiationEric C Ko, Eric M Genden, Krzysztof Misiukiewicz, et al.
Translational Lung Cancer Research|July 8, 2024
Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic <i>EGFR</i>-mutated non-small cell lung cancer: present and future developmentsXinchen Zhao, Shengwei Zhang, Xiaoyue Sun, et al.
Brachytherapy|February 16, 2010
Partial vs. whole breast irradiation in a community hospital: a retrospective cohort analysis of 200 patientsEric C Ko, Christopher D Koprowski, Diana Dickson-Witmer, et al.
Pageof 3